Long-acting injectable drugs could help schizophrenics stay on medication longer
Alkermes Plc said on Tuesday its long-acting injectable therapy for schizophrenia has helped reduce symptoms and can become an effective option for ensuring patients stay on medication even after being discharged from hospital.
from Reuters: Health News https://reut.rs/2IkZ3QM
http://bit.ly/2zwRqiM
April 09, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on April 09, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.